As of Feb 27
| 0.00 / 0.00%|
The 1 analysts offering 12-month price forecasts for Anthera Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a -0.99% decrease from the last price of 5.05.
The current consensus among 1 polled investment analysts is to Buy stock in Anthera Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.